Cytonome Contact Us   |   Site Map   |   Home 
Products Technology Services And Support News And Events Resources About Us

Email A Friend

Board of Directors | Management | Scientific Advisory Board

Cytonome has assembled a team of managers with over 100 man years experience in instrument design, applied biollogical science, public accounting and business development.    The Cytonome team is uniquely positioned to bring the revolutionary Gigasort technology to market.

John C. Sharpe, Ph.D. Chief Executive Officer

Dr. John C. Sharpe is the Chief Executive Officer of Cytonome.  He was a former Director of Photara Technologies, a Business Manager for Dexcel N.Z, and a Director of R&D for DakoCytomation with project management responsibilities for developing laser-based cell sorting technology.    Dr. Sharpe holds a Ph.D. from Waikato University

 

Lydia Villa-Komaroff Ph.D. Chief Scientific Officer

Dr. Lydia Villa-Komaroff is the Chief Scientific Officer at Cytonome. During her 20 year research career, Dr. Villa-Komaroff has held positions at MIT, Harvard University, University of Massachusetts Medical School and Harvard Medical School.  As a science administrator, she has been VP for Research at Northwestern University in Illinois and the Vice President for Research and Chief Operating Officer of Whitehead Institute for Biomedical Research in Cambridge, MA.  She also served as Chair of the Board of Directors of Transkaryotic Therapies.

 

Jack Lapidas, MBA Vice President of Business Development

Jack Lapidas is the Vice President of Business Development at Cytonome. Mr. Lapidas previously led Coventor's business development efforts in its microfluidics and biotechnology division and has more than 10 years of executive level business development and marketing experience.  He holds Bachelor of Science and Master of Business Administration degrees from Cornell University.

 

 

 

 


 

Heather Ellerkamp, MBA Chief Financial Officer

Heather Ellerkamp is the Chief Financial Officer at Cytonome. Prior to joining Cytonome as Chief Financial Officer, Ms. Ellerkamp was the Treasurer and Director of Finance for AutoImmune Inc, a biopharmaceutical company. She has a Bachelor of Arts from the University of California, San Diego, and a Master of Business Administration from the University of Michigan. 

 

 

 

Email A Friend            

Defining Cells For Life

© 2005 Cytonome, Inc.   All rights reserved. 
Terms of Use     Privacy Policy
Site design and developed by Melrose Asset

  * Use in patient studies requires compliance with FDA requirements or the requirements of other appropriate national regulatory authorities. Gigasort™ systems have no specificity as to which cells are separated. To separate selected cell types, the user supplies the reagents that provide cell specificity and sets program parameters of the Gigasort™ system to conform to the user's protocol specifications.